Related Experiment Videos
Developmental hematopoiesis in normal human fetal blood
F Forestier1, F Daffos, N Catherine
1Service de Médicine et de Biologie Foetales, Institut de Puériculture de Paris, France.
Blood
|June 1, 1991
Summary
This study analyzed fetal blood samples to establish normal values for prenatal diagnosis. Findings reveal key changes in fetal red blood cells, hemoglobin, and cell populations during development.
Area of Science:
- Hematology
- Prenatal Medicine
- Fetal Physiology
Background:
- Prenatal diagnosis relies on accurate fetal blood analysis.
- Establishing normal reference ranges for fetal hematological parameters is crucial for identifying abnormalities.
Purpose of the Study:
- To define normal reference values for fetal blood cell counts and erythropoiesis markers.
- To provide a baseline for assessing fetal hematological health during gestation.
Main Methods:
- Analysis of 2,860 normal fetal blood samples obtained via in utero sampling from 18 weeks gestation to term.
- Evaluation of total nucleated cell counts, platelet counts, differentials, Burst-forming unit erythroid (BFU-E), and erythropoietin (Epo).
Main Results:
- Total nucleated cell and platelet counts remained stable between 18 and 30 weeks gestation.
- Lymphocytes were the predominant cell type; neutrophils increased as normoblastic cells decreased.
- Significant increases in red blood cells and hemoglobin were observed throughout gestation; BFU-E levels were higher at mid-trimester compared to birth.
- Erythropoietin (Epo) levels were stable, with no correlation to gestational age.
Conclusions:
- Established normal values for fetal erythropoiesis provide essential physiological data.
- These findings enhance understanding of developmental hematopoiesis and aid in prenatal diagnosis.